Rui Wang

Rui Wang is a highly experienced professional in the field of immunology and pharmacology. They have held various leadership roles in companies such as Quotient Therapeutics, Fuhong Therapeutics, and AbbVie, contributing significantly to target validation and identification in autoimmune diseases, cancer, and metabolic conditions. Rui's educational background includes a Ph.D. in Immunology from New York University and a B.S. in Biology from Peking University.